BE901980A - Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.

Info

Publication number
BE901980A
BE901980A BE1/011217A BE1011217A BE901980A BE 901980 A BE901980 A BE 901980A BE 1/011217 A BE1/011217 A BE 1/011217A BE 1011217 A BE1011217 A BE 1011217A BE 901980 A BE901980 A BE 901980A
Authority
BE
Belgium
Prior art keywords
medicaments
preparation
cyclosporin derivatives
novel cyclosporin
novel
Prior art date
Application number
BE1/011217A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE901980A publication Critical patent/BE901980A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE1/011217A 1984-03-23 1985-03-21 Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments. BE901980A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (1)

Publication Number Publication Date
BE901980A true BE901980A (fr) 1985-09-23

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011217A BE901980A (fr) 1984-03-23 1985-03-21 Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.

Country Status (24)

Country Link
US (1) US4639434A (enExample)
JP (1) JPH08838B2 (enExample)
AT (1) AT388737B (enExample)
BE (1) BE901980A (enExample)
CA (1) CA1247546A (enExample)
CH (1) CH667274A5 (enExample)
CS (1) CS249542B2 (enExample)
DE (1) DE3509809A1 (enExample)
DK (1) DK128285A (enExample)
ES (1) ES8702926A1 (enExample)
FI (1) FI851120L (enExample)
FR (1) FR2561651B1 (enExample)
GB (1) GB2155936B (enExample)
GR (1) GR850716B (enExample)
HU (1) HU200786B (enExample)
IL (1) IL74681A (enExample)
IT (1) IT1199962B (enExample)
LU (1) LU85819A1 (enExample)
NL (1) NL8500828A (enExample)
NO (1) NO851160L (enExample)
NZ (1) NZ211526A (enExample)
PH (2) PH21868A (enExample)
PT (1) PT80149B (enExample)
SE (1) SE461334B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290762B1 (en) 1984-10-04 1993-05-12 Sandoz Ag Cyclosporins
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
EP0391909B1 (en) * 1987-09-03 1994-08-17 The University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (enExample) * 1988-05-13 1991-12-31 Sandoz Ag
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
ES2095926T5 (es) * 1990-11-02 2001-02-16 Novartis Ag Cyclosporins.
ES2091301T3 (es) * 1990-11-20 1996-11-01 Behringwerke Ag Inmunoensayo de ciclosporina.
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP4261049B2 (ja) 1997-10-08 2009-04-30 アイソテクニカ インコーポレイテッド 重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
WO2003032949A1 (en) * 2001-10-19 2003-04-24 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
HRP20070058B1 (hr) * 2001-10-19 2014-05-23 Isotechnika Inc. Sinteza ciklosporinskih analoga
WO2004082629A2 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
EP1809656A4 (en) * 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
JP2008514702A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
WO2006041631A2 (en) * 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
KR20190002731A (ko) 2010-12-15 2019-01-08 콘트라빌 파마슈티컬스, 인코퍼레이티드 아미노산 1 및 3에서 변형된 사이클로스포린 유사체 분자
HUE044591T2 (hu) 2011-03-11 2019-11-28 Beth Israel Deaconess Medical Ct Inc Anti-CD40 antitestek és alkalmazásuk
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
KR102779818B1 (ko) 2015-09-04 2025-03-11 프리마토프 테라퓨틱스 인크. 인간화 항-cd40 항체 및 그의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins

Also Published As

Publication number Publication date
FI851120A0 (fi) 1985-03-20
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
DK128285A (da) 1985-09-24
PH23357A (en) 1989-07-14
PH21868A (en) 1988-03-25
FR2561651B1 (fr) 1990-03-09
US4639434A (en) 1987-01-27
JPS60215700A (ja) 1985-10-29
GB2155936A (en) 1985-10-02
NL8500828A (nl) 1985-10-16
ES8702926A1 (es) 1987-01-16
CS249542B2 (en) 1987-03-12
AT388737B (de) 1989-08-25
IL74681A (en) 1989-09-10
SE8501392D0 (sv) 1985-03-21
LU85819A1 (fr) 1985-12-12
PT80149B (en) 1987-03-23
ES541465A0 (es) 1987-01-16
JPH08838B2 (ja) 1996-01-10
SE8501392L (sv) 1985-09-24
GB8507270D0 (en) 1985-04-24
IT8547852A0 (it) 1985-03-22
FI851120A7 (fi) 1985-09-24
HUT38370A (en) 1986-05-28
GR850716B (enExample) 1985-07-19
SE461334B (sv) 1990-02-05
NO851160L (no) 1985-09-24
GB2155936B (en) 1987-09-16
CH667274A5 (de) 1988-09-30
HU200786B (en) 1990-08-28
PT80149A (en) 1985-04-01
DE3509809A1 (de) 1986-01-09
FR2561651A1 (fr) 1985-09-27
NZ211526A (en) 1988-08-30
FI851120L (fi) 1985-09-24
IT1199962B (it) 1989-01-05
IL74681A0 (en) 1985-06-30
IT8547852A1 (it) 1986-09-22
DK128285D0 (da) 1985-03-21

Similar Documents

Publication Publication Date Title
BE901980A (fr) Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments.
AU588860B2 (en) Improvements in or relating to organic compounds
BE1003071A5 (fr) Nouveaux inhibiteurs de la renine, leur preparation et leur utilisation comme medicaments.
FR2432503A1 (fr) Nouveaux nonapeptides, leur procede de preparation et leur application comme medicaments
BE905954A (fr) Preparation pulverisable de dihydropyridine, son procede de production et son utilisation pharmaceutique.
FR2607493B1 (fr) Nouveaux composes pharmacologiquement actifs, leurs procedes de preparation et les compositions en contenant
HUP9900338A2 (hu) Sokfunkciós enzim
DE3683823D1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
CA2331870A1 (fr) Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR930006027A (ko) 엔케팔리나제 및 안지오텐신 전환 효소(ace)의 억제제로서 유용한 2-치환 인단-2-메르캅토아세틸아미드 유도체
BE1002213A5 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
BE904233A (fr) Peptides et derives peptidiques, leur preparation, leur utilisation en therapeutique et compositions pharmaceutiques les contenant.
BE904368A (fr) Nouveaux derives de pyridylmethoxy- et methylmercaptoanilines, utiles notamment comme antiasthmatiques, leur fabrication et medicaments les contenant.
IE861997L (en) Zwitterionic bicyclic compounds
BE1002663A4 (fr) Nouveaux derives de la somatostatine, leur preparation et leur utilisation comme medicaments.
BE901456A (fr) Nouvelles 8 alpha-acylaminoergolines, leur preparation et leur utilisation comme medicaments.
FR2608159B1 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments
BE905790A (fr) Peptide de venin de serpent arretant la croissance.
EP0272174A3 (fr) Préparations d'adenyl cyclase purifiées, procédé d'obtention de ces préparations et leurs applications biologiques
IE872239L (en) Pyridopyrimidinediones and quinazolines
FR2622446B1 (fr) Agent pour reduire la nephrotoxicite produite par l'administration de cyclosporine
MA20926A1 (fr) Composes heterocycliques azotes nouveaux, compositions les contenant, leur preparation et leur application pour reduire la perte d'humidite de plantes et pour accroitre le rendement de cultures.
FR2692899B1 (fr) Nouveaux dérivés peptidiques actifs dans les processus d'adhésion cellulaire, leur procédé de préparation et les compositions pharmaceutiques qui les renferment.
BE899526A (fr) Nouveaux derives d'acylaminophenols, leur preparation et leur utilisation comme medicaments.
BE1003219A3 (fr) NOUVEAUX DERIVES DE L'OCTAHYDROBENZO[g]QUINOLEINE, LEUR PREPARATION ET LEUR UTILISATION COMME MEDICAMENTS.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: NOVARTIS A.G.

Effective date: 19990331